Please login to the form below

Not currently logged in
Email:
Password:

AZ's Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge
Mene Pangalos

AstraZeneca's Mene Pangalos, executive VP of IMED Biotech, has been appointed in two new positions based in Cambridge.

Pangalos will join the board of the Precision Medicine Catapult, the newly established centre in Cambridge designed to shape the future of precision medicine in the UK.

In his role as non-executive director, Pangalos will provide a pharmaceutical industry perspective on how to ensure the UK can remain at the cutting edge of precision medicine.

Additionally, Pangalos has also been appointed an as official fellow of Clare Hall College in the University of Cambridge.

Pangalos said: “I'm delighted to receive these two appointments. Although they are a great personal honour, I believe they are testament to the quality of our science, our pioneering approach to personalised healthcare and our long standing commitment to strengthening the UK life science sector.”    

13th November 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics